
Sinacort0.1%
Ibn-Sina Pharmaceuticals Ltd.
Betamethasone Valerate is a mid-potency topical corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Betamethasone Valerate is a mid-potency topical corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Betamethasone Valerate should be used only for the corticosteroid-responsive skin condition diagnosed and prescribed by a physician; it is not intended for indiscriminate or self-directed use on undiagnosed skin lesions.
Betamethasone Valerate should be applied as a thin film to the affected skin area only, using the smallest amount and shortest duration needed to control symptoms.
| Indication | Population | Typical Regimen |
|---|---|---|
| Corticosteroid-responsive dermatoses (eczema, psoriasis [excluding widespread plaque psoriasis], neurodermatitis, seborrhoeic dermatitis, contact dermatitis, discoid lupus erythematosus, prurigo nodularis) | Adults | Apply a thin film to the affected area 1–3 times daily until improvement occurs; once control is achieved, reduce to once or twice daily, or apply less frequently as directed by a physician. |
| Same indications, lotion formulation | Adults | Apply a few drops and massage gently into the affected area, usually twice daily (morning and night); frequency may be adjusted by a physician based on response. |
| Corticosteroid-responsive dermatoses | Children aged 1 year and older | Apply sparingly, once or twice daily, for the shortest duration that controls symptoms, under physician supervision; avoid occlusive dressings. |
| Any indication | Infants under 1 year | Not recommended — see Pediatric Use. |
Continuous treatment with Betamethasone Valerate is generally not recommended beyond about 2–4 weeks without medical reassessment; if there is no improvement within 2 weeks, treatment should be reviewed by a physician. See also Duration of Treatment.
Local skin reactions are the most common adverse effects of Betamethasone Valerate and are usually related to the strength, duration, and area of application:
With extensive use, prolonged use, use under occlusion, or use on large areas or broken skin, systemic absorption of Betamethasone Valerate can occur, which may rarely cause features of hypercorticism (Cushingoid features), HPA-axis suppression, hyperglycemia, and glucosuria — see Precautions and Warnings.
Betamethasone Valerate is contraindicated in:
Betamethasone Valerate is for dermatologic (skin) use only and must not be used in or near the eyes.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.